PUBLICAÇÕES científicas

/cun/pt/investigacion/publicaciones-cientificas/areaMain/02
  • Tolerogenic dendritic cell-based treatment for multiple sclerosis

    Willekens B# (1,2), Presas-Rodríguez S# (3,4), Mansilla MJ (5,6), Derdelinckx J (1,2), Lee WP (7), Nijs G (7), De Laere M (2), Wens I (2), Cras P (1), Parizel P (8), Van Hecke W (9), Ribbens A (9), Billiet T (9), Adams G (10), Couttenye MM 11, Navarro-Barriuso J (5,6), Teniente-Serra A (5,6), Quirant-Sánchez B (5,6), Lopez-Diaz de Cerio A (12,13), Inogés S (12,13), Prosper F (12,14), Kip A (15), Verheij H (15), Gross CC (16,17), Wiendl H (16,17), Van Ham MS (18,19), Ten Brinke A (18,19), Barriocanal AM (20,21), Massuet-Vilamajó A (22), Hens N (23,24), Berneman Z (2,7), Martínez-Cáceres E (5), Cools N# (25,7), Ramo-Tello C# (26); RESTORE consortium.

    (1) Department of Neurology, University Hospital Antwerp, Edegem, Belgium.
    (2) Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp Faculty of Medicine and Health Sciences, Wilrijk, Belgium.
    (3) Multiple Sclerosis Unit, Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
    (4) Department of Medicine, Universitat Autònoma de Barcelona, Cerdanyola del Vallés, Spain.
    (5) Division of Immunology, LCMN, Hospital Universitario Germans Trias i Pujol and Research Institute, Badalona, Spain.
    (6) Department of Cellular Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Bellaterra, Spain.
    (7) Center for Cell Therapy and Regenerative Medicine, University Hospital Antwerp, Edegem, Belgium.
    (8) Department of Radiology, University Hospital Antwerp, Edegem, Belgium.
    (9) Icometrix NV, Leuven, Belgium.
    (10) C-Clear Partners, Mortsel, Belgium.
    (11) Department of Nephrology, University Hospital Antwerp, Edegem, Belgium.
    (12) Haematology-Cell Therapy Area, clinica universidad de navarra, Pamplona, Spain.
    (13) Immunology and Immunotherapy Department, Clinica Universidad de Navarra, Pamplona, Spain.
    (14) Program of Haematology-Oncology, CIMA, Universidad de Navarra, Pamplona, Spain.
    (15) Lygature, Utrecht, The Netherlands.
    (16) Department of Neurology, University Hospital Munster, Munster, Germany.
    (17) Department of Neurology, University of Munster, Munster, Germany.
    (18) Department of Immunopathology, Sanquin Research, Amsterdam, The Netherlands.
    (19) Landsteiner Laboratory, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
    (20) Clinical Research Polyvalent Unit, Clinial Trial Unit-Spanish Clinical Research Network, Germans Trias i Pujol Health Sciences Research Institute, Badalona, Spain.
    (21) Department of Pharmacology, Therapeutic and Toxicology, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain.
    (22) Institut de Diagnòstic per la Imatge, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
    (23) Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BioStat), Universiteit Hasselt, Hasselt, Belgium.
    (24) Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO) & Center for Statistics, University of Antwerp Faculty of Medicine and Health Sciences, Wilrijk, Belgium.
    (25) Laboratory of Experimental Hematology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp Faculty of Medicine and Health Sciences, Wilrijk, Belgium
    (26) Multiple Sclerosis Unit, Department of Neurosciences, Hospital Universitari Germans Trias i Pujol, Badalona, Spain
    # Contributed equally

    BMJ Open 09 de SETEMBRO de 2019

  • The Importance of Gender-Related Anticancer Research on Mitochondrial Regulator Sodium Dichloroacetate in Preclinical Studies In Vivo

    Stakišaitis D (1,2), Juknevičienė M (3), Damanskienė E (3), Valančiūtė A (3), Balnytė I (3), Alonso MM (4).

    (1) Laboratory of Molecular Oncology, National Cancer Institute, 08660 Vilnius, Lithuania.
    (2) Department of Histology and Embryology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
    (3) Department of Histology and Embryology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
    (4) Department of Pediatrics, Clínica Universidad de Navarra, University of Navarra, 55 Pamplona, Spain.

    Cancers 20 de AGOSTO de 2019

  • The immediate efficacy of inhaled nitric oxide treatment in preterm infants with acute respiratory failure during neonatal transport

    Garrido F (1,2), Gonzalez-Caballero JL (3), Lomax R (1), Dady I (1).

    (1) Connect NW, Manchester University NHS Foundation Trust, Newborn Intensive Care Services, St. Mary's Hospital, Oxford Road, Manchester, M13 9WL.
    (2) Clínica Universidad de Navarra, NICU, Madrid, Spain.
    (3) Department of Statistics and Operative Research, University of Cádiz, Facultad de Medicina, Plaza Fragela s/n, Cádiz, Spain.

    Acta Paediatrica 02 de AGOSTO de 2019

  • Treatment of Type 2 Diabetes by Patient Profile in the Clinical Practice of Endocrinology in Spain

    Morillas C (1), Escalada J (2), Palomares R (3), Bellido D (4), Gómez-Peralta F (5), Pérez A (6).

    (1) Hospital Universitario Doctor Peset, Valencia, Spain.
    (2) Clínica Universidad de Navarra, Pamplona, Spain.
    (3) Hospital Universitario Reina Sofía, Córdoba, Spain.
    (4) Hospital Arquitecto Marcide, Complejo Hospitalario Universitario de Ferrol [CHUF], El Ferrol, Spain.
    (5) Hospital General de Segovia, c/Luis Erik Clavería neurólogo s/n, Segovia, Spain.
    (6) Hospital de la Santa Creu i Sant Pau, CIBERDEM, c/de Sant Quintí, Barcelona, Spain.

    Diabetes Therapy 29 de JULHO de 2019

  • The Urgent Surgery Elderly Mortality risk score: a simple mortality score

    Eguaras Córdoba I (1), Herrera Cabezón J (2), Sánchez Acedo P (1), Galbete Jiménez A (3), Guillén Grima F (4).

    (1) Cirugía General, Complejo Hospitalario de Navarra, España.
    (2) Cirugía General/ Jefe Unidad Hepatobiliopancreatic, Complejo Hospitalario de Navarra, España.
    (3) NAVARRABIOMED - Centro de Investigación Biomédica, Navarrabiomed, España.
    (4) Departamento de Medicina Preventiva, Clinica Universidad de Navarra, España.

    Revista Española de Enfermedades Digestivas 18 de JULHO de 2019

talvezlhe interesse

QUE TECNOLOGIA UTILIZAMOS? 

A Clínica é o hospital privado com maiores recursos tecnológicos de Espanha, tudo num único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OS NOSSOS
PROFISSIONAIS

Os profissionais da Clínica realizam um trabalho contínuo de investigação e formação, sempre em benefício do paciente.

Imagen profesionales de la Clínica Universidad de Navarra

RAZÕES PARA VIR
À CLÍNICA

Conheça porque é que somos diferentes em relação a outros centros sanitários. Qualidade, rapidez, comodidade e resultados.

Imagen del edificio de la Clínica Universidad de Navarra